The NCT05989048 trial examined a single dose of intranasal zavegepant for one moderate or severe migraine attack. Explore the participant criteria, outcome measures, reported findings, and study limitations.
The ACHIEVE-3 Phase 3 trial compared oral orforglipron with oral semaglutide in adults with type 2 diabetes inadequately controlled with metformin, evaluating HbA1c, weight, and safety over 52 weeks.
Introduction Small cell lung cancer (SCLC) can progress despite initial platinum-based chemotherapy, leaving patients with limited treatment options. The DeLLphi-304 trial evaluated tarlatamab against standard-of-care
The Phase 3 APHENITY trial studied sepiapterin in people with phenylketonuria (PKU). Learn how the trial was designed, what researchers found about blood phenylalanine levels, what safety results were reported, and what the findings mean.
The SUMMIT trial studied tirzepatide in people with heart failure with preserved ejection fraction (HFpEF) and obesity. Learn about the study design, results, safety findings, and what the trial reported.
What did the Danuglipron trial find in people with obesity? Explore the study design, treatment, results, side effects, and what the findings mean in plain language.
The BELINDA trial compared a tisagenlecleucel treatment strategy with standard care in adults with aggressive B-cell non-Hodgkin lymphoma. Learn about the study design, event-free survival results, safety findings, and limitations.
Explore the REACT Phase 3 trial results of clazosentan for aneurysmal subarachnoid hemorrhage, including the study design, key findings, safety results, and what the research means in plain language.
Clear, evidence-based explanations of clinical trials, study results, and medical research—written in plain language.
